Lundbeck
HLUN-B.CO
#2798
Rank
โ‚น555.66 B
Marketcap
โ‚น560.06
Share price
-2.55%
Change (1 day)
18.76%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Revenue for Lundbeck (HLUN-B.CO)

Revenue in 2025 (TTM): โ‚น332.58 Billion

According to Lundbeck's latest financial reports the company's current revenue (TTM ) is โ‚น345.94 Billion. an increase over the revenue in the year 2024 that were of โ‚น272.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lundbeck from 2009 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น341.25 B25.16%
2024 โ‚น272.64 B13.18%
2023 โ‚น240.89 B12.98%
2022 โ‚น213.21 B12.47%
2021 โ‚น189.57 B-5.45%
2020 โ‚น200.49 B8.23%
2019 โ‚น185.24 B-6.1%
2018 โ‚น197.28 B16.16%
2017 โ‚น169.84 B7.67%
2016 โ‚น157.73 B10.39%
2015 โ‚น142.89 B-4.71%
2014 โ‚น149.95 B-10.53%
2013 โ‚น167.59 B18.28%
2012 โ‚น141.69 B-9.42%
2011 โ‚น156.43 B32.92%
2010 โ‚น117.69 B-2.35%
2009 โ‚น120.53 B